Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-10-27ClinicalTrials.gov study NCT00091689
-
CLINICAL_TRIALS study record update · 2008-10-24Prospectively Randomized Phase III Study of an Individualized Sensitivity-Directed Combination Chemotherapy Versus DTIC as First-Line Treatment in Stage IV Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2008-08-05Phase II Open-Label Study of Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemo
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant
-
CLINICAL_TRIALS study record update · 2008-03-04A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-03-04Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2008-03-04Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
-
CLINICAL_TRIALS study record update · 2008-03-04Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
-
CLINICAL_TRIALS study record update · 2008-01-15A Phase II, Randomized, Open-Label Study Evaluating The Antitumor Activity Of MEDI-522, A Humanized Monoclonal Antibody Directed Against The Human Alpha V Beta 3 Integrin, ± Dacarbazine In Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2007-12-06A Randomized Phase II Trial of ATN-224 in Combination With Temozolomide or Temozolomide Followed by ATN-224 in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2007-11-16Phase I/II Clinical Trial for the Evaluation of the Interaction Between Chemotherapy and Immunotherapy in Melanoma Patients
-
CLINICAL_TRIALS study record update · 2007-09-27MicroRNA Expression and Function in Cutaneous Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2007-09-20A Phase IIa Study to Evaluate Safety, Tolerability, and Immunogenicity of a Melan-A VLP Vaccine in HLA-A2 Positive Patients With Stage III/IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2007-08-23A Phase 1 Safety and Tolerability Study of Intralesional PV-10 Chemoablation in Subjects With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2007-08-14Phase I Clinical Trial of a Therapeutic Vaccine Composed of Autologous Dendritic Cells Loaded With Allogeneic Apoptotic Tumor Cells in Patients With Melanoma Stages IIB, IIC, III and IV
-
CLINICAL_TRIALS study record update · 2007-06-08ClinicalTrials.gov study NCT00083252
-
CLINICAL_TRIALS study record update · 2007-06-08ClinicalTrials.gov study NCT00083239
-
CLINICAL_TRIALS study record update · 2007-03-01Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema Following Plaque Radiotherapy for Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2006-12-06ClinicalTrials.gov study NCT00406900